Search Results - David W Vredevoogd

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance by Julia Boshuizen, David W. Vredevoogd, Oscar Krijgsman, Maarten A. Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T. Frederick, Juliana C. N. Kenski, Mara Parren, Marieke Brüggemann, Max F. Madu, Elisa A. Rozeman, Ji-Ying Song, Hugo M. Horlings, Christian U. Blank, Alexander C. J. van Akkooi, Keith T. Flaherty, Genevieve M. Boland, Daniel S. Peeper

    Published in Nature Communications (2023-02-01)
    Get full text
    Article


  2. 2

    TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction by Gal Markel, Michal J Besser, Eytan Ruppin, Oscar Krijgsman, Daniel S Peeper, Judit Díaz-Gómez, Ettai Markovits, David W Vredevoogd, Georgi Apriamashvili, Pierre L Levy, Sanju Sinha, Zowi R Huinen, Nils L Visser, Beaunelle de Bruijn, Julia Boshuizen, Susan E van Hal-van Veen, Maarten A Ligtenberg, Onno B Bleijerveld, Chun-Pu Lin, Santiago Duro Sánchez, Juan Simon Nieto, Alex van Vliet, Maarten Altelaar

    Published in Journal for ImmunoTherapy of Cancer (2024-11-01)
    Get full text
    Article


Search Tools: